Reports
Sale
Global Pneumatic Nebulizer Market Size, Share, Forecast By Product Type: Breath Actuated Nebulizer, Vented Nebulizer; By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Others; By End User: Hospitals and Clinics, Ambulatory Surgical Centres, Others; Regional Analysis; Competitive Landscape; 2024-2032
Global Pneumatic Nebulizer Market Outlook
The global pneumatic nebulizer market size was valued at USD 782.4 million in 2023, driven by the increasing geriatric population across the globe. The market size is anticipated to grow at a CAGR of 6.8% during the forecast period of 2024-2032 to achieve a value of USD 1416.1 million by 2032.
Pneumatic Nebulizer: Introduction
A nebulizer is a drug delivery device that is used to administer medication in the form of a mist inhaled into the lungs. Nebulizers are commonly used for the treatment of asthma, cystic fibrosis, COPD, and other respiratory diseases or disorders. They use oxygen, compressed air, or ultrasonic power to break up solutions and suspensions into small aerosol droplets that are inhaled from the mouthpiece of the device. An aerosol is a mixture of gas and solid or liquid particles.
Global Pneumatic Nebulizer Market Analysis
The market is witnessing significant growth driven by increased technological advancements. The growth is also influenced by other trends such as key players launching new products and rapid technological advancements. For example, the launch of the MicroAir Ultra Compact Nebulizer by Omron Healthcare in the United States was a key development in the market. This compact, portable nebulizer is designed to be easy to use at home or on the go. It also features new QuietFlow technology enabling noise reduction. Production and distribution of such innovative products can potentially contribute to the global pneumatic nebulizers market growth.
The healthcare sector is also experiencing a significant rise in telemedicine and remote patient monitoring, which is attributed to the increased adoption of pneumatic nebulizers by healthcare providers, due to the ability to remotely monitor and provide patient guidance through these devices. This rise and intense adoption of pneumatic nebulizers is expected to drive the market growth further in the coming years.
Global Pneumatic Nebulizer Market Segmentations
Market Breakup by Product Type
- Breath Actuated Nebulizer
- Vented Nebulizer
Market Breakup by Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Cystic Fibrosis
- Others
Market Breakup by End User
- Hospitals and Clinics
- Ambulatory Surgical Centres
- Home Healthcare
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Pneumatic Nebulizer Market Overview
The market is witnessing significant growth driven by the rising geriatric population. The increasing healthcare expenditure across several nations and the urgent need to curb these expenses are anticipated to increase the adoption of home healthcare devices driving the market growth. The market is also driven by the easy availability of compact pneumatic nebulizers ideal for home use increasing the demand in the market. The wave of technological innovations in these devices to reduce the noise produced while using and to improve their functionality, are also increasing their adoption in healthcare settings. The increasing incidence of chronic respiratory diseases and increasing demand for home healthcare devices coupled with the growing geriatric population are major factors expected to aid the growing pneumatic nebulizer market demand.
Geographically, North America is leading the regional market and is expected to keep leading in the coming years as well. The region is leading due to the high incidence of Chronic Obstructive Pulmonary Disease COPD. According to the American Lung Association (ALA), 24 million American adults are expected to be suffering from COPD. The region is also dominating due to the rising geriatric population, directly contributing to the growth in the number of surgeries, further boosting the regional market growth.
Global Pneumatic Nebulizer Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Koninklijke Philips N.V.
- DeVilbiss Healthcare
- OMRON Corporation
- PARI Pharma
- Briggs Healthcare
- General Electric Company
- Heyer Medical AG
- Allied Healthcare Products, Inc.
- Vectura Group plc
- Phillips Respironics
- Agilent Technologies Inc.
- Salter Labs
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Pneumatic Nebulizer Market Overview
3.1 Global Pneumatic Nebulizer Market Historical Value (2017-2023)
3.2 Global Pneumatic Nebulizer Market Forecast Value (2024-2032)
4 Global Pneumatic Nebulizer Market Landscape
4.1 Global Pneumatic Nebulizer Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Pneumatic Nebulizer Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Application
5 Global Pneumatic Nebulizer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Pneumatic Nebulizer Market Segmentation
6.1 Global Pneumatic Nebulizer Market by Product Type
6.1.1 Market Overview
6.1.2 Breath Actuated Nebulizer
6.1.3 Vented Nebulizer
6.2 Global Pneumatic Nebulizer Market by Application
6.2.1 Market Overview
6.2.2 Chronic Obstructive Pulmonary Disease (COPD)
6.2.3 Asthma
6.2.4 Cystic Fibrosis
6.2.5 Others
6.3 Global Pneumatic Nebulizer Market by End User
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Ambulatory Surgical Centres
6.3.4 Home Healthcare
6.3.5 Others
6.4 Global Pneumatic Nebulizer Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Pneumatic Nebulizer Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Pneumatic Nebulizer Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Pneumatic Nebulizer Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Pneumatic Nebulizer Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Pneumatic Nebulizer Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Koninklijke Philips N.V.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 DeVilbiss Healthcare
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 OMRON Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 PARI Pharma
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Briggs Healthcare
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 General Electric Company
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Heyer Medical AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Allied Healthcare Products, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Vectura Group plc
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Phillips Respironics
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Agilent Technologies Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Salter Labs
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Pneumatic Nebulizer Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 782.4 million in 2023, driven by the increased geriatric population.
The market is anticipated to grow at a CAGR of 6.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 1416.1 million by 2032.
The increasing geriatric population and increasing prevalence of chronic diseases across the globe are among the major factors driving the market growth.
The new product launches by key players in the market are a major trend influencing market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Various products in the market include breath-actuated nebulizers and vented nebulizers.
They find wide applications in chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, among others.
End users in the market are hospitals and clinics, ambulatory surgical centres, and home healthcare, among others.
Key players involved in the market are Koninklijke Philips N.V., DeVilbiss Healthcare, OMRON Corporation, PARI Pharma, Briggs Healthcare, General Electric Company, Heyer Medical AG, Allied Healthcare Products, Inc., Vectura Group plc, Phillips Respironics, Agilent Technologies Inc., and Salter Labs.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER